Hedge Fund News: Bill Ackman, Steven Heinz & Sac Capital Advisors

Three weeks ago Quebec based pharmaceuticals company Valeant Pharmaceuticals Intl Inc (NYSE:VRX) made a US$47 billion hostile takeover bid, in cash and stock, to acquire Irvine...

Keep Reading →